Androgen-Independent Prostate Cancer Is Sensitive to CDC42-PAK7 Kinase Inhibition.

Han, Hyunho; Park, Cheol Keun; Choi, Young-Deuk; Cho, Nam Hoon; Lee, Jongsoo; Cho, Kang Su

Han, Hyunho; Park, Cheol Keun; Choi, Young-Deuk; Cho, Nam Hoon; Lee, Jongsoo; Cho, Kang Su.

Afiliação

Han H; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Park CK; Department of Pathology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Choi YD; Pathology Center, Seegene Medical Foundation, Seoul 04805, Republic of Korea.
Cho NH; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Lee J; Department of Pathology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Cho KS; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

Biomedicines ; 11(1)2022 Dec 30.

Article em En | MEDLINE | ID: mdl-36672609

Palavras-chave

RNA-binding proteins; androgen deprivation therapy; castration-resistant prostate cancer; prostate cancer; staints

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google